InvestorsObserver
×
News Home

Will Amphastar Pharmaceuticals Inc (AMPH) Outperform the Rest of the Stocks in the Healthcare Sector?

Friday, February 25, 2022 02:42 PM | InvestorsObserver Analysts

Mentioned in this article

Will Amphastar Pharmaceuticals Inc (AMPH) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 92 puts Amphastar Pharmaceuticals Inc (AMPH) near the top of the Healthcare sector according to InvestorsObserver. Amphastar Pharmaceuticals Inc's score of 92 means that it ranks higher than 92% of stocks in the sector. In addition, its overall score of 91 ranks it higher than 91% of all stocks.

Overall Score - 91
AMPH has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on AMPH!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 91 means the stock is more attractive than 91 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Amphastar Pharmaceuticals Inc Stock Today?

Amphastar Pharmaceuticals Inc (AMPH) stock is trading at $28.74 as of 2:42 PM on Friday, Feb 25, a rise of $1.18, or 4.26% from the previous closing price of $27.56. The stock has traded between $27.64 and $29.19 so far today. Volume today is 395,903 compared to average volume of 347,700. Click Here to get the full Stock Report for Amphastar Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App